HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Metastatic Squamous Neck Cancer

Metastatic squamous neck cancer refers to a type of cancer that has originated in the squamous cells of the neck and has spread to other parts of the body. Squamous cells are thin, flat cells lining various surfaces in the body. When cancerous cells from the neck region metastasize, they can invade nearby tissues and migrate to distant organs through the bloodstream or lymphatic system. This aggressive form of cancer poses significant challenges in terms of diagnosis and treatment. Metastatic squamous neck cancer often involves lymph nodes and may affect vital structures in the neck, such as the throat, voice box, and surrounding tissues. The condition is commonly associated with risk factors such as smoking, excessive alcohol consumption, and human papillomavirus (HPV) infection. Due to its advanced stage at the time of diagnosis, treatment options for metastatic squamous neck cancer typically involve a combination of surgery, radiation therapy, and chemotherapy. The goal is to control the spread of the cancer, alleviate symptoms, and improve the patient's quality of life. Palliative care may also be incorporated to address pain and discomfort associated with the disease. Prognosis for metastatic squamous neck cancer can vary depending on factors such as the extent of metastasis, overall health of the patient, and response to treatment. The medical team will work closely with the individual to create a personalized treatment plan and provide supportive care throughout the journey. It is essential for individuals at risk or experiencing symptoms related to squamous neck cancer to seek prompt medical attention. Early detection and intervention can significantly impact the outcome and enhance the chances of effective treatment. Regular screenings and adopting a healthy lifestyle are crucial in reducing the risk of developing this aggressive form of cancer.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp